Treatment Trends Following GLP-1 Agonist-associated Weight Loss Featuring Dr. Joely Kaufman
Joely Kaufman, MD, breaks down the findings of a new survey of healthcare providers that looked at the impact of glucagon-like peptide-1 (GLP-1) receptor agonist-associated weight loss.